top of page
LiverExir
TM
iPSC-Derived Cynomolgus Hepatocytes for In Vitro Drug Safety Assessment and Cross-Species Comparison with Human Hepatocytes
Worried about liver toxicity showing up late in NHP in vivo studies? Why not evaluate it earlier in vitro?
In Vitro drug testing on NHP-derived Liver Cells to reduce risk prior to In Vivo studies
Use primate In Vitro Liver Cells to investigate mechanisms behind In Vivo Liver Toxicity
Cyno iPSC-derived hepatocyte
Using LiverExir comparative studies between human and NHP hepatocytes helps species selection and efficient preclinical efficacy and toxicity evaluations.
bottom of page